U.S. market Closed. Opens in 2 hours 42 minutes

VIRX | Viracta Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
RevenueN/AN/AN/A120.00K2.07M237.00K669.00K2.54M3.06M5.73M7.96M3.75M5.00M33.08K3.76M5.42M9.66M13.71M16.52M10.30M
Cost of Revenue492.00K210.00K178.00K32.00KN/A-902.75K9.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A10.30M
Gross Profit-492.00K-210.00K-178.00K88.00K2.07M1.14M660.00K2.54M3.06M5.73M7.96M3.75M5.00M33.08K3.76M5.42M9.66M13.71M16.52MN/A
Operating Expenses50.69M50.59M25.80M18.82M25.36M25.94M35.08M38.98M42.34M50.78M39.73M38.36M30.87M21.44M21.00M37.81M49.63M47.87M44.45M28.80M
Selling, General & Admin17.32M24.33M15.44M5.35M9.95M11.32M13.54M16.10M18.64M23.11M10.84M9.18M8.30M7.00M7.75M11.52M13.57M12.25M8.28M5.18M
Research & Development33.37M26.26M23.86M13.47M15.41M14.62M21.54M22.88M23.70M27.66M28.89M29.18M22.56M14.43M13.25M26.29M36.06M35.62M36.17M23.62M
Other Operating ExpensesN/A1.39M-13.50M-34.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A1.92B1.92B5.78M1.56MN/AN/AN/A
Operating Income-50.69M-50.59M62.50M-18.82M-23.29M-25.71M-34.42M-36.46M-39.30M-41.28M-31.68M-42.10M-19.84M-24.59M-40.22M-37.01M-38.55M-30.76M-26.82M-20.66M
Other Expenses / Income-365.00K1.39M-75.46M-202.00K-42.00K-905.00K-1.04M-1.56M2.63M2.04M-2.83M-9.35M5.72M-24.57B-22.99M989.37K-1.56M3.41M428.12K132.58K
Before Tax Income-51.06M-49.20M-114.76M-19.02M-23.33M-26.61M-35.46M-38.02M-36.68M-43.00M-34.60M-43.95M-20.14M-24.59M-63.24M-37.19M-40.11M-30.75M-26.81M-20.53M
Income Tax ExpensesN/A577.00K88.30M182.00K514.00K1.15M1.40M1.72M939.00K1.72M2.92M1.85M300.00K-21.08B1.19K171.31K209.88K477.64K674.16KN/A
Net Income-51.06M-49.77M-203.06M-19.20M-23.33M-26.61M-35.46M-38.02M-36.68M-44.72M-37.52M-45.81M-20.44M-24.59M-63.24M-37.36M-40.32M-31.23M-27.49M-20.53M
Interest Expenses3.70M577.00K491.00K216.00K514.00K1.15M1.40M1.72M939.00K1.72M2.92M1.85M300.00KN/A1.19K171.31K209.88K477.64K674.16K386.75K
Basic Shares Outstanding38.62M37.79M31.87M92.78K2.49M1.02M700.46K448.23K347.30K1.00M870.82K802.43K773.53K414.34K95.52K95.52K89.83K77.11K63.80K17.03K
Diluted Shares Outstanding38.62M37.79M31.87M92.78K2.49M1.02M700.46K448.23K347.30K1.03M870.82K802.43K773.53K414.34K95.52K95.52K89.83K77.11K63.80K17.03K
EBITDA-46.86M-48.41M-114.09M-18.77M-22.82M-25.45M-34.05M-36.29M-35.71M-41.25M-31.66M-42.06M-20.09M-24.44M-39.88M-35.91M-36.82M-29.18M-25.14M-17.97M
EBITDA Margin0.00%0.00%0.00%-15,640.83%-1,100.63%-10,739.24%-5,090.13%-1,431.03%-1,166.61%-719.46%-397.95%-1,120.54%-401.70%-73,866.51%-1,060.29%-662.88%-381.04%-212.83%-152.17%-174.41%
EBIT-47.35M-48.62M-114.27M-18.80M-22.30M-24.31M-32.67M-34.58M-34.80M-41.28M-31.68M-42.10M-19.84M-21.10B-63.24M-37.01M-39.90M-30.28M-26.14M-20.14M
EBIT Margin0.00%0.00%0.00%-15,667.50%-1,075.83%-10,256.12%-4,882.81%-1,363.60%-1,136.82%-719.97%-398.20%-1,121.36%-396.82%-63,784,307.61%-1,681.13%-683.26%-412.87%-220.84%-158.22%-195.47%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙